Currently, there are 52.29M common shares owned by the public and among those 52.28M shares have been available to trade.
The company’s stock has a 5-day price change of 16.32% and -68.29% over the past three months. APDN shares are trading -98.33% year to date (YTD), with the 12-month market performance down to -98.39% lower. It has a 12-month low price of $0.12 and touched a high of $14.40 over the same period. APDN has an average intraday trading volume of 6.04 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 8.92%, 0.56%, and -89.16% respectively.
Institutional ownership of Applied Dna Sciences Inc (NASDAQ: APDN) shares accounts for 2.06% of the company’s 52.29M shares outstanding.
It has a market capitalization of $10.84M and a beta (3y monthly) value of 0.44. The earnings-per-share (ttm) stands at -$6.89. Price movements for the stock have been influenced by the stock’s volatility, which stands at 14.25% over the week and 22.49% over the month.
Analysts forecast that Applied Dna Sciences Inc (APDN) will achieve an EPS of -0.33 for the current quarter, -0.33 for the next quarter and 0 for current fiscal year. The lowest estimate earnings-per-share for the quarter is -0.33 while analysts give the company a high EPS estimate of -0.33. Comparatively, EPS for the current quarter was -5.51 a year ago.
Looking at the support for the APDN, a number of firms have released research notes about the stock. ROTH Capital stated their Buy rating for the stock in a research note on February 12, 2021, with the firm’s price target at $24. H.C. Wainwright coverage for the Applied Dna Sciences Inc (APDN) stock in a research note released on January 14, 2021 offered a Buy rating with a price target of $14. H.C. Wainwright was of a view on December 18, 2020 that the stock is Buy, while H.C. Wainwright gave the stock Buy rating on July 20, 2020, issuing a price target of $18- $22. H.C. Wainwright on their part issued Buy rating on July 02, 2020.
